BDMD · Baird Medical Investment Holdings Ltd · Metrics
Market Cap
$3.45M
Shares
32.11M
Volume · Nov 12
101.84M
Avg daily vol (3M)
15.19M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
BDMD metrics
58 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$0.11
Market cap
$3.45M
Price action
23 metricsPrice change (1W)
-4.7%
Price change (30D)
-84.8%
Price change (3M)
-91.2%
Price change (6M)
-93.9%
Price change (YTD)
-92.4%
Price change (1Y)
-91.6%
Trailing year
Price change (5Y)
—
52-week high
$3.44
52-week low
$0.09
Change from 52-week high
-97.0%
Change from 52-week low
+18.2%
Annualized volatility
147.9%
Annualized volatility (3M)
188.6%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.4
RSI (14D)
22.2
Price vs SMA 50
-84.0%
Price vs SMA 200
-92.0%
Avg volume (3M)
13.63M
Relative volume
11.1
Average dollar volume
$1.87M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
32.11M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 733.4%
P / book
0.1
reciprocal yield 1,041.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
85.6%
Operating margin
-58.5%
Trailing 12 months
Net margin
-121.0%
Gross profit (TTM)
$20.97M
Operating profit (TTM)
−$14.33M
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-39.2%
Year over year
Net income growth YoY
-319.0%
Revenue (TTM)
$24.49M
Trailing 12 months
EPS growth YoY
-271.9%
Shares change YoY
+27.3%
Year over year · more shares
Revenue CAGR (3Y)
-13.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-87.0%
Return on assets
-39.1%
Debt / equity
—
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
-20.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$178,321
Total assets
$73.85M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
$14.34M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
58.6%
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
10
13F filer change QoQ
+2
Institutional ownership
19.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1.8%
Holder tenure
3.1
Price vs estimated holder cost
-45.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.7%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
45 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—